TY - JOUR AU - Gelmon, K. AU - Dent, R. AU - Mackey, J. R. AU - Laing, K. AU - McLeod, D. AU - Verma, S. PY - 2012 DA - 2012// TI - Targeting triple-negative breast cancer: optimising therapeutic outcomes JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds067 DO - 10.1093/annonc/mds067 ID - Gelmon2012 ER - TY - JOUR AU - Crown, J. AU - O’Shaughnessy, J. AU - Gullo, G. PY - 2012 DA - 2012// TI - Emerging targeted therapies in triple-negative breast cancer JO - Ann Oncol. VL - 23 UR - https://doi.org/10.1093/annonc/mds196 DO - 10.1093/annonc/mds196 ID - Crown2012 ER - TY - JOUR AU - Dent, R. AU - Trudeau, M. AU - Pritchard, K. I. AU - Hanna, W. M. AU - Kahn, H. K. AU - Sawka, C. A. PY - 2007 DA - 2007// TI - Triple-negative breast cancer: clinical features and patterns of recurrence JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3045 DO - 10.1158/1078-0432.CCR-06-3045 ID - Dent2007 ER - TY - JOUR AU - O’Reilly, E. A. AU - Gubbins, L. AU - Sharma, S. AU - Tully, R. AU - Guang, M. H. AU - Weiner-Gorzel, K. PY - 2015 DA - 2015// TI - The fate of chemoresistance in triple negative breast cancer (TNBC) JO - BBA Clin. VL - 3 UR - https://doi.org/10.1016/j.bbacli.2015.03.003 DO - 10.1016/j.bbacli.2015.03.003 ID - O’Reilly2015 ER - TY - JOUR AU - Baselga, J. AU - Albanell, J. AU - Ruiz, A. AU - Lluch, A. AU - Gascon, P. AU - Guillem, V. PY - 2005 DA - 2005// TI - Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.08.326 DO - 10.1200/JCO.2005.08.326 ID - Baselga2005 ER - TY - JOUR AU - Carey, L. A. AU - Rugo, H. S. AU - Marcom, P. K. AU - Mayer, E. L. AU - Esteva, F. J. AU - Ma, C. X. PY - 2012 DA - 2012// TI - TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.34.5579 DO - 10.1200/JCO.2010.34.5579 ID - Carey2012 ER - TY - JOUR AU - Nabholtz, J. M. AU - Chalabi, N. AU - Radosevic-Robin, N. AU - Dauplat, M. M. AU - Mouret-Reynier, M. A. AU - Praagh, I. PY - 2016 DA - 2016// TI - Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer JO - Int J Cancer VL - 138 UR - https://doi.org/10.1002/ijc.29952 DO - 10.1002/ijc.29952 ID - Nabholtz2016 ER - TY - JOUR AU - Black, J. L. AU - Harrell, J. C. AU - Leisner, T. M. AU - Fellmeth, M. J. AU - George, S. D. AU - Reinhold, D. PY - 2015 DA - 2015// TI - CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer JO - Breast Cancer Res Treat VL - 152 UR - https://doi.org/10.1007/s10549-015-3458-4 DO - 10.1007/s10549-015-3458-4 ID - Black2015 ER - TY - JOUR AU - Leisner, T. M. AU - Moran, C. AU - Holly, S. P. AU - Parise, L. V. PY - 2013 DA - 2013// TI - CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.408 DO - 10.1038/onc.2012.408 ID - Leisner2013 ER - TY - JOUR AU - Lemke, J. AU - Karstedt, S. AU - Zinngrebe, J. AU - Walczak, H. PY - 2014 DA - 2014// TI - Getting TRAIL back on track for cancer therapy JO - Cell Death Differ VL - 21 UR - https://doi.org/10.1038/cdd.2014.81 DO - 10.1038/cdd.2014.81 ID - Lemke2014 ER - TY - JOUR AU - Zhang, L. AU - Fang, B. PY - 2005 DA - 2005// TI - Mechanisms of resistance to TRAIL-induced apoptosis in cancer JO - Cancer Gene Ther VL - 12 UR - https://doi.org/10.1038/sj.cgt.7700792 DO - 10.1038/sj.cgt.7700792 ID - Zhang2005 ER - TY - JOUR AU - Refaat, A. AU - Abd-Rabou, A. AU - Reda, A. PY - 2014 DA - 2014// TI - TRAIL combinations: the new ‘trail’ for cancer therapy (Review) JO - Oncol Lett. VL - 7 UR - https://doi.org/10.3892/ol.2014.1922 DO - 10.3892/ol.2014.1922 ID - Refaat2014 ER - TY - JOUR AU - So, J. AU - Pasculescu, A. AU - Dai, A. Y. AU - Williton, K. AU - James, A. AU - Nguyen, V. PY - 2015 DA - 2015// TI - Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy JO - Sci Signal VL - 8 UR - https://doi.org/10.1126/scisignal.2005700 DO - 10.1126/scisignal.2005700 ID - So2015 ER - TY - JOUR AU - Strekalova, E. AU - Malin, D. AU - Rajanala, H. AU - Cryns, V. L. PY - 2017 DA - 2017// TI - Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression JO - Breast Cancer Res Treat VL - 163 UR - https://doi.org/10.1007/s10549-017-4201-0 DO - 10.1007/s10549-017-4201-0 ID - Strekalova2017 ER - TY - JOUR AU - Pommier, Y. AU - Sordet, O. AU - Antony, S. AU - Hayward, R. L. AU - Kohn, K. W. PY - 2004 DA - 2004// TI - Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207515 DO - 10.1038/sj.onc.1207515 ID - Pommier2004 ER - TY - JOUR AU - Tait, S. W. AU - Ichim, G. AU - Green, D. R. PY - 2014 DA - 2014// TI - Die another way—non-apoptotic mechanisms of cell death JO - J Cell Sci VL - 127 UR - https://doi.org/10.1242/jcs.093575 DO - 10.1242/jcs.093575 ID - Tait2014 ER - TY - JOUR AU - Sperandio, S. AU - Poksay, K. AU - Belle, I. AU - Lafuente, M. J. AU - Liu, B. AU - Nasir, J. PY - 2004 DA - 2004// TI - Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix JO - Cell Death Differ VL - 11 UR - https://doi.org/10.1038/sj.cdd.4401465 DO - 10.1038/sj.cdd.4401465 ID - Sperandio2004 ER - TY - JOUR AU - Ghosh, K. AU - De, S. AU - Das, S. AU - Mukherjee, S. AU - Sengupta, B. a. n. d. y. o. p. a. d. h. y. a. y. S. PY - 2016 DA - 2016// TI - Withaferin A induces ROS-mediated paraptosis in human breast cancer cell-lines MCF-7 and MDA-MB-231 JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0168488 DO - 10.1371/journal.pone.0168488 ID - Ghosh2016 ER - TY - JOUR AU - Bissig, C. AU - Gruenberg, J. PY - 2014 DA - 2014// TI - ALIX and the multivesicular endosome: ALIX in Wonderland JO - Trends Cell Biol VL - 24 UR - https://doi.org/10.1016/j.tcb.2013.10.009 DO - 10.1016/j.tcb.2013.10.009 ID - Bissig2014 ER - TY - JOUR AU - Yoon, M. J. AU - Kim, E. H. AU - Lim, J. H. AU - Kwon, T. K. AU - Choi, K. S. PY - 2010 DA - 2010// TI - Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells JO - Free Radic Biol Med. VL - 48 UR - https://doi.org/10.1016/j.freeradbiomed.2009.12.016 DO - 10.1016/j.freeradbiomed.2009.12.016 ID - Yoon2010 ER - TY - JOUR AU - Ram, B. M. AU - Ramakrishna, G. PY - 2014 DA - 2014// TI - Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition JO - Biochim Biophys Acta VL - 1843 UR - https://doi.org/10.1016/j.bbamcr.2014.06.020 DO - 10.1016/j.bbamcr.2014.06.020 ID - Ram2014 ER - TY - JOUR AU - Avelar-Freitas, B. A. AU - Almeida, V. G. AU - Pinto, M. C. AU - Mourao, F. A. AU - Massensini, A. R. AU - Martins-Filho, O. A. PY - 2014 DA - 2014// TI - Trypan blue exclusion assay by flow cytometry JO - Braz J Med Biol Res VL - 47 UR - https://doi.org/10.1590/1414-431X20143437 DO - 10.1590/1414-431X20143437 ID - Avelar-Freitas2014 ER - TY - JOUR AU - Sprick, M. R. AU - Rieser, E. AU - Stahl, H. AU - Grosse-Wilde, A. AU - Weigand, M. A. AU - Walczak, H. PY - 2002 DA - 2002// TI - Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8 JO - EMBO J VL - 21 UR - https://doi.org/10.1093/emboj/cdf441 DO - 10.1093/emboj/cdf441 ID - Sprick2002 ER - TY - JOUR AU - Schug, Z. T. AU - Gonzalvez, F. AU - Houtkooper, R. H. AU - Vaz, F. M. AU - Gottlieb, E. PY - 2011 DA - 2011// TI - BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane JO - Cell Death Differ VL - 18 UR - https://doi.org/10.1038/cdd.2010.135 DO - 10.1038/cdd.2010.135 ID - Schug2011 ER - TY - JOUR AU - Tsujimoto, Y. PY - 2012 DA - 2012// TI - Multiple ways to die: non-apoptotic forms of cell death JO - Acta Oncol VL - 51 UR - https://doi.org/10.3109/0284186X.2011.648340 DO - 10.3109/0284186X.2011.648340 ID - Tsujimoto2012 ER - TY - JOUR AU - Pronsato, L. AU - Colla, A. AU - Ronda, A. C. AU - Milanesi, L. AU - Boland, R. AU - Vasconsuelo, A. PY - 2013 DA - 2013// TI - High passage numbers induce resistance to apoptosis in C2C12 muscle cells JO - Biocell. VL - 37 ID - Pronsato2013 ER - TY - JOUR AU - Shiau, J. Y. AU - Nakagawa-Goto, K. AU - Lee, K. H. AU - Shyur, L. F. PY - 2017 DA - 2017// TI - Phytoagent deoxyelephantopin derivative inhibits triple negative breast cancer cell activity by inducing oxidative stress-mediated paraptosis-like cell death JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.18183 DO - 10.18632/oncotarget.18183 ID - Shiau2017 ER - TY - JOUR AU - Carey, L. A. AU - Dees, E. C. AU - Sawyer, L. AU - Gatti, L. AU - Moore, D. T. AU - Collichio, F. PY - 2007 DA - 2007// TI - The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1109 DO - 10.1158/1078-0432.CCR-06-1109 ID - Carey2007 ER - TY - JOUR AU - Corkery, B. AU - Crown, J. AU - Clynes, M. AU - O’Donovan, N. PY - 2009 DA - 2009// TI - Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn710 DO - 10.1093/annonc/mdn710 ID - Corkery2009 ER - TY - JOUR AU - Lehmann, B. D. AU - Bauer, J. A. AU - Chen, X. AU - Sanders, M. E. AU - Chakravarthy, A. B. AU - Shyr, Y. PY - 2011 DA - 2011// TI - Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies JO - J Clin Invest. VL - 121 UR - https://doi.org/10.1172/JCI45014 DO - 10.1172/JCI45014 ID - Lehmann2011 ER - TY - JOUR AU - Bauer, J. A. AU - Ye, F. AU - Marshall, C. B. AU - Lehmann, B. D. AU - Pendleton, C. S. AU - Shyr, Y. PY - 2010 DA - 2010// TI - RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells JO - Breast Cancer Res VL - 12 UR - https://doi.org/10.1186/bcr2595 DO - 10.1186/bcr2595 ID - Bauer2010 ER - TY - JOUR AU - Peleg, R. AU - Bobilev, D. AU - Priel, E. PY - 2014 DA - 2014// TI - Topoisomerase I as a target of erlotinib and gefitinib: efficacy of combined treatments with camptothecin JO - Int J Oncol VL - 44 UR - https://doi.org/10.3892/ijo.2014.2244 DO - 10.3892/ijo.2014.2244 ID - Peleg2014 ER - TY - JOUR AU - McClendon, A. K. AU - Dean, J. L. AU - Rivadeneira, D. B. AU - Yu, J. E. AU - Reed, C. A. AU - Gao, E. PY - 2012 DA - 2012// TI - CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.21127 DO - 10.4161/cc.21127 ID - McClendon2012 ER - TY - JOUR AU - Beuvink, I. AU - Boulay, A. AU - Fumagalli, S. AU - Zilbermann, F. AU - Ruetz, S. AU - O’Reilly, T. PY - 2005 DA - 2005// TI - The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation JO - Cell VL - 120 UR - https://doi.org/10.1016/j.cell.2004.12.040 DO - 10.1016/j.cell.2004.12.040 ID - Beuvink2005 ER - TY - JOUR AU - Hastak, K. AU - Alli, E. AU - Ford, J. M. PY - 2010 DA - 2010// TI - Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-4521 DO - 10.1158/0008-5472.CAN-09-4521 ID - Hastak2010 ER - TY - JOUR AU - Mondesire, W. H. AU - Jian, W. AU - Zhang, H. AU - Ensor, J. AU - Hung, M. C. AU - Mills, G. B. PY - 2004 DA - 2004// TI - Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0361 DO - 10.1158/1078-0432.CCR-04-0361 ID - Mondesire2004 ER - TY - JOUR AU - Okada, H. AU - Mak, T. W. PY - 2004 DA - 2004// TI - Pathways of apoptotic and non-apoptotic death in tumour cells JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1412 DO - 10.1038/nrc1412 ID - Okada2004 ER - TY - JOUR AU - Han, W. AU - Li, L. AU - Qiu, S. AU - Lu, Q. AU - Pan, Q. AU - Gu, Y. PY - 2007 DA - 2007// TI - Shikonin circumvents cancer drug resistance by induction of a necroptotic death JO - Mol Cancer Ther VL - 6 UR - https://doi.org/10.1158/1535-7163.MCT-06-0511 DO - 10.1158/1535-7163.MCT-06-0511 ID - Han2007 ER - TY - JOUR AU - Trivedi, R. AU - Mishra, D. P. PY - 2015 DA - 2015// TI - Trailing TRAIL resistance: novel targets for TRAIL sensitization in cancer cells JO - Front Oncol VL - 5 UR - https://doi.org/10.3389/fonc.2015.00069 DO - 10.3389/fonc.2015.00069 ID - Trivedi2015 ER - TY - JOUR AU - Mauro-Lizcano, M. AU - Lopez-Rivas, A. PY - 2018 DA - 2018// TI - Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells JO - Cell Death Dis. VL - 9 UR - https://doi.org/10.1038/s41419-018-0263-0 DO - 10.1038/s41419-018-0263-0 ID - Mauro-Lizcano2018 ER - TY - JOUR AU - Shigeno, M. AU - Nakao, K. AU - Ichikawa, T. AU - Suzuki, K. AU - Kawakami, A. AU - Abiru, S. PY - 2003 DA - 2003// TI - Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206139 DO - 10.1038/sj.onc.1206139 ID - Shigeno2003 ER - TY - JOUR AU - Hung, C. M. AU - Liu, L. C. AU - Ho, C. T. AU - Lin, Y. C. AU - Way, T. D. PY - 2017 DA - 2017// TI - Pterostilbene enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistance triple negative breast cancer cells JO - J Agric Food Chem VL - 65 UR - https://doi.org/10.1021/acs.jafc.7b02358 DO - 10.1021/acs.jafc.7b02358 ID - Hung2017 ER - TY - JOUR AU - Singh, T. R. AU - Shankar, S. AU - Chen, X. AU - Asim, M. AU - Srivastava, R. K. PY - 2003 DA - 2003// TI - Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo JO - Cancer Res VL - 63 ID - Singh2003 ER - TY - JOUR AU - Allensworth, J. L. AU - Aird, K. M. AU - Aldrich, A. J. AU - Batinic-Haberle, I. AU - Devi, G. R. PY - 2012 DA - 2012// TI - XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0787 DO - 10.1158/1535-7163.MCT-11-0787 ID - Allensworth2012 ER - TY - JOUR AU - Abdelhamed, S. AU - Yokoyama, S. AU - Hafiyani, L. AU - Kalauni, S. K. AU - Hayakawa, Y. AU - Awale, S. PY - 2013 DA - 2013// TI - Identification of plant extracts sensitizing breast cancer cells to TRAIL JO - Oncol Rep VL - 29 UR - https://doi.org/10.3892/or.2013.2293 DO - 10.3892/or.2013.2293 ID - Abdelhamed2013 ER - TY - JOUR AU - Wang, S. AU - El-Deiry, W. S. PY - 2003 DA - 2003// TI - TRAIL and apoptosis induction by TNF-family death receptors JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207232 DO - 10.1038/sj.onc.1207232 ID - Wang2003 ER - TY - JOUR AU - Hu, W. H. AU - Johnson, H. AU - Shu, H. B. PY - 1999 DA - 1999// TI - Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.43.30603 DO - 10.1074/jbc.274.43.30603 ID - Hu1999 ER - TY - JOUR AU - Su, Z. AU - Yang, Z. AU - Xie, L. AU - DeWitt, J. P. AU - Chen, Y. PY - 2016 DA - 2016// TI - Cancer therapy in the necroptosis era JO - Cell Death Differ VL - 23 UR - https://doi.org/10.1038/cdd.2016.8 DO - 10.1038/cdd.2016.8 ID - Su2016 ER - TY - JOUR AU - Bury, M. AU - Girault, A. AU - Megalizzi, V. AU - Spiegl-Kreinecker, S. AU - Mathieu, V. AU - Berger, W. PY - 2013 DA - 2013// TI - Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity JO - Cell Death Dis. VL - 4 UR - https://doi.org/10.1038/cddis.2013.85 DO - 10.1038/cddis.2013.85 ID - Bury2013 ER - TY - JOUR AU - Christofferson, D. E. AU - Yuan, J. PY - 2010 DA - 2010// TI - Necroptosis as an alternative form of programmed cell death JO - Curr Opin Cell Biol VL - 22 UR - https://doi.org/10.1016/j.ceb.2009.12.003 DO - 10.1016/j.ceb.2009.12.003 ID - Christofferson2010 ER -